Promoting Arrhythmia Susceptibility-Reference-Cited by-同舟云学术

Promoting Arrhythmia Susceptibility

Published:2006-01-24 Issue:3 Volume:113 Page:330-332
ISSN:0009-7322
Container-title:Circulation
language:en
Short-container-title:Circulation

Author:

Bunch T. Jared¹,Ackerman Michael J.¹

Affiliation:

1. From the Department of Internal Medicine, Division of Cardiovascular Medicine (T.J.B., M.J.A.), Department of Pediatrics, Division of Pediatric Cardiology (M.J.A.), and Department of Molecular Pharmacology and Experimental Therapeutics (M.J.A.), Mayo Clinic College of Medicine, Rochester, Minn.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Physiology (medical),Cardiology and Cardiovascular Medicine

Link

https://www.ahajournals.org/doi/pdf/10.1161/CIRCULATIONAHA.105.595454

Reference20 articles.

1. SCN5A mutations associated with an inherited cardiac arrhythmia, long QT syndrome

2. Brugada Syndrome: Report of the Second Consensus Conference

3. Genetic and biophysical basis of sudden unexplained nocturnal death syndrome (SUNDS), a disease allelic to Brugada syndrome

4. Genetic basis and molecular mechanism for idiopathic ventricular fibrillation

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. SCN5A promoter haplotype affects the therapeutic range for serum flecainide concentration in Asian patients;Pharmacogenetics and Genomics;2013-07

2. Advances in the prevention of sudden cardiac death in the young;Therapeutic Advances in Cardiovascular Disease;2009-01-26

3. A NovelSCN5AMutation in a Patient with Coexistence of Brugada Syndrome Traits and Ischaemic Heart Disease;Case Reports in Medicine;2009

4. SCN5A variants in Japanese patients with left ventricular noncompaction and arrhythmia;Molecular Genetics and Metabolism;2008-04

5. Ablation vs. drug use for atrial fibrillation;European Heart Journal Supplements;2007-09-01